Hims & Hers Health Inc (HIMS) Presyo ng Stock at Balita

(USD)	Set 2024	Y/Y na pagbabago
Kita	401.56M	77.13%
Gastos sa pagpapatakbo	295.51M	50.88%
Net na kita	75.59M	1,098.92%
Net profit margin	18.82	663.47%
Kita sa bawat share	0.43	682.40%
EBITDA	26.76M	532.19%
Aktuwal na % ng binabayarang buwis	-220.38%	—

Balance Sheet

Kabuuang asset

Kabuuang sagutin

(USD)	Set 2024	Y/Y na pagbabago
Cash at mga panandaliang investment	254.07M	19.56%
Kabuuang asset	602.26M	45.52%
Kabuuang sagutin	162.21M	90.16%
Kabuuang equity	440.05M	—
Natitirang share	218.48M	—
Presyo para makapag-book	15.77	—
Return on assets	10.33%	—
Return on capital	13.56%	—

Cash Flow

Net change in cash

(USD)	Set 2024	Y/Y na pagbabago
Net na kita	75.59M	1,098.92%
Cash mula sa mga operasyon	85.27M	238.48%
Cash mula sa pag-invest	-10.41M	66.47%
Cash mula sa financing	-38.82M	-2,390.06%
Net change in cash	36.22M	588.11%
Malayang cash flow	72.52M	158.41%

Tungkol

Hims & Hers Health, Inc. is an American telehealth company established in 2017. The company provides prescription medications, over-the-counter medications, and personal care products. Hims & Hers operates with a direct-to-consumer model. Consumers consult licensed healthcare professionals and access treatments and products through the company's platform. Customers pay for a consultation with a doctor to prescribe the drug along with the price of the drug itself. The company has expanded its offerings to include health solutions for both men and women, along with mental health services. Wikipedia

Itinatag

Nob 2017

Headquarters

San Francisco, California
Estados Unidos

Website

forhims.com

Mga Empleyado

1,046